Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

Market Cap	8.94B
Revenue (ttm)	3.21B
Net Income (ttm)	326.41M
Shares Out	454.66M
EPS (ttm)	0.71
PE Ratio	27.64
Forward PE	20.37
Dividend	0.30 (1.53%)
Ex-Dividend Date	May 21, 2025

Volume	7,095,500
Average Volume	9,540,040
Open	19.75
Previous Close	19.40
Day's Range	19.34 - 19.75
52-Week Range	11.25 - 28.90
Beta	0.38
RSI	43.78
Earnings Date	Aug 26, 2025

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company offers anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poultry...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,900
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300119

Financial Performance

In 2024, SHE:300119's revenue was 3.07 billion, an increase of 13.32% compared to the previous year's 2.71 billion. Earnings were 300.72 million, a decrease of -33.70%.